Cargando…

Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma

Pancreatic cancer is a molecularly heterogeneous disease. Epigenetic changes and epigenetic regulatory mechanisms underlie at least some of this heterogeneity and contribute to the evolution of aggressive tumor biology in patients and the tumor’s intrinsic resistance to therapy. Here we review our c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, Joyce K., Bednar, Filip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715475/ https://www.ncbi.nlm.nih.gov/pubmed/34968245 http://dx.doi.org/10.3390/epigenomes5040020

Ejemplares similares

Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment
por: Elrakaybi, Asmaa, et al.
Publicado: (2022)

Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
por: Kawakubo, Kazumichi, et al.
Publicado: (2022)

Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
por: Ciernikova, Sona, et al.
Publicado: (2020)

Bmi1 Enhances Tumorigenicity and Cancer Stem Cell Function in Pancreatic Adenocarcinoma
por: Proctor, Erica, et al.
Publicado: (2013)

Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies
por: Pham, Thao N. D., et al.
Publicado: (2021)

Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
por: Li, Yan, et al.
Publicado: (2022)

An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma
por: Sarnecka, Agnieszka K., et al.
Publicado: (2016)

Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma
por: Roalsø, Marcus T. T., et al.
Publicado: (2022)

Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma
por: Xu, Rui, et al.
Publicado: (2019)

Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
por: Kawakubo, Kazumichi, et al.
Publicado: (2022)

Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications
por: Silverman, Brittany R., et al.
Publicado: (2016)

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma
por: Ferguson, L. Paige, et al.
Publicado: (2023)

Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine
por: McCormack, Steven E, et al.
Publicado: (2010)

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication
por: Hung, Yu-Hsuan, et al.
Publicado: (2019)

Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth
por: Vincent, Audrey, et al.
Publicado: (2014)

Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma
por: Mardin, Wolf Arif, et al.
Publicado: (2013)

What is the origin of pancreatic adenocarcinoma?
por: Pour, Parviz M, et al.
Publicado: (2003)

RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
por: Amato, Eliana, et al.
Publicado: (2016)

Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies
por: Bimonte, Sabrina, et al.
Publicado: (2016)

Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis
por: Kamarajah, Sivesh K., et al.
Publicado: (2020)

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma
por: Loft, Matthew, et al.
Publicado: (2019)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Utility of CT to Differentiate Pancreatic Parenchymal Metastasis from Pancreatic Ductal Adenocarcinoma
por: Barat, Maxime, et al.
Publicado: (2021)

Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential
por: Cannon, Andrew, et al.
Publicado: (2018)

Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis
por: Hara, Yutaro, et al.
Publicado: (2023)

Epigenetic Alterations in Pancreatic Cancer Metastasis
por: Wang, Sarah S., et al.
Publicado: (2021)

Epigenetic Control of Pancreatic Regeneration in Diabetes
por: Balaji, Shruti, et al.
Publicado: (2018)

Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
por: Gutiérrez, María Laura, et al.
Publicado: (2021)

Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Skorupan, Nebojsa, et al.
Publicado: (2022)

Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma
por: Liu, Zhao, et al.
Publicado: (2023)

Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
por: Kung, Heng‐Chung, et al.
Publicado: (2023)

Epigenetic Alterations from Barrett’s Esophagus to Esophageal Adenocarcinoma
por: Ergun, Pelin, et al.
Publicado: (2023)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Omics Approaches in Pancreatic Adenocarcinoma
por: González-Borja, Iranzu, et al.
Publicado: (2019)

Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
por: Daniel, S. K., et al.
Publicado: (2019)

Translating genetic and epigenetic knowledge into clinical utility
por: Rosenquist, Richard
Publicado: (2018)

Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”
por: Hester, Robert, et al.
Publicado: (2021)

Pancreatic Adenocarcinoma Invasiveness and the Tumor Microenvironment: From Biology to Clinical Trials
por: Mejia, Isabel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kcdqubgoqru8j6l2vkd5u9aocn